C1q腫瘤壞死因子相關蛋白9(C1QTNF9)多克隆抗體
Polyclonal Antibody to C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9)
CTRP9; C1QTNF9A; AQL1; Complement C1q and tumor necrosis factor-related protein 9A
- 編號PAR877Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPR877Hu01-C1q腫瘤壞死因子相關蛋白9(C1QTNF9)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Mus musculus (Mouse，小鼠)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 695¥ 1621¥ 2316¥ 5790¥ 23160
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
IHC圖
Figure. Western Blot; Sample: Recombinant C1QTNF9, Human.
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對C1QTNF9的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別C1QTNF9。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPR877Hu01 | C1q腫瘤壞死因子相關蛋白9(C1QTNF9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAR877Hu01 | C1q腫瘤壞死因子相關蛋白9(C1QTNF9)多克隆抗體 | WB; IHC; ICC; IP. |
| MAR877Hu21 | C1q腫瘤壞死因子相關蛋白9(C1QTNF9)單克隆抗體 | WB; IHC; ICC; IP. |
| SER877Hu | C1q腫瘤壞死因子相關蛋白9(C1QTNF9)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMR877Hu | C1q腫瘤壞死因子相關蛋白9(C1QTNF9)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Int J Obes (Lond). | Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans.[Pubmed: 24357853] |
| J Clin Endocrinol Metab.? | Association of Serum C1q/TNF-Related Protein-9 Concentration With Arterial Stiffness in Subjects With Type 2 Diabetes[Pubmed:25105737] |
| J Clin Endocrinol Metab.? | C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery[Pubmed:26982010] |
| PLoS One. | Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose.[pubmed:28207876] |
| Journal?of?Diabetes?Research | Plasma?C1q/TNF-Related?Protein-9?Levels?Are?Associated?with?Atherosclerosis?in?Patients?withType?2?Diabetes?without?Renal?Dysfunction.[pubmed:28070523] |
| diabetes?research?and?clinical?practice | Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance[pubmed:28743061] |
| PLoS One | Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery?…[Pubmed:29381773] |
| archives of insect biochemistry and physiology | Effect of a single bout of resistance exercise on zinc-α2-glycoprotein[Pubmed: 31686532] |
| J Diabetes Investig | Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus[33417302] |
| Neurol Ther | Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke[34727346] |